137 related articles for article (PubMed ID: 7843268)
21. P2-purinoceptor antagonists: II. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue.
Wittenburg H; Bültmann R; Pause B; Ganter C; Kurz G; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):491-7. PubMed ID: 8897453
[TBL] [Abstract][Full Text] [Related]
22. The novel heteromeric bivalent ligand SB9 potently antagonizes P2Y(1) receptor-mediated responses.
Lambrecht G; Ganso M; Bäumert HG; Spatz-Kümbel G; Hildebrandt C; Braun K; Mutschler E
J Auton Nerv Syst; 2000 Jul; 81(1-3):171-7. PubMed ID: 10869717
[TBL] [Abstract][Full Text] [Related]
23. Evidence for two distinct P2-purinoceptors subserving contraction of the rat anococcygeus smooth muscle.
Najbar AT; Li CG; Rand MJ
Br J Pharmacol; 1996 Jun; 118(3):537-42. PubMed ID: 8762075
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder.
Bailey SJ; Hourani SM
Br J Pharmacol; 1994 May; 112(1):219-25. PubMed ID: 8032645
[TBL] [Abstract][Full Text] [Related]
25. Effects of metal cations on [3H]alpha,beta-methylene ATP binding in rat vas deferens.
Michel AD; Humphrey PP
Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug; 350(2):113-22. PubMed ID: 7990967
[TBL] [Abstract][Full Text] [Related]
26. The purinergic component of human vas deferens contraction.
Banks FC; Knight GE; Calvert RC; Thompson CS; Morgan RJ; Burnstock G
Fertil Steril; 2006 Apr; 85(4):932-9. PubMed ID: 16580377
[TBL] [Abstract][Full Text] [Related]
27. Purinergic contraction of the rat vas deferens in L-NAME-induced hypertension: effect of sildenafil.
Gur S; Sikka SC; Knight GE; Burnstock G; Hellstrom WJ
Asian J Androl; 2010 May; 12(3):415-21. PubMed ID: 20305675
[TBL] [Abstract][Full Text] [Related]
28. Evidence that [3H]-alpha,beta-methylene ATP may label an endothelial-derived cell line 5'-nucleotidase with high affinity.
Michel AD; Chau NM; Fan TP; Frost EE; Humphrey PP
Br J Pharmacol; 1995 Jul; 115(5):767-74. PubMed ID: 8548175
[TBL] [Abstract][Full Text] [Related]
29. Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vessels.
Ziganshin AU; Hoyle CH; Lambrecht G; Mutschler E; Bümert HG; Burnstock G
Br J Pharmacol; 1994 Mar; 111(3):923-9. PubMed ID: 8019770
[TBL] [Abstract][Full Text] [Related]
30. Solubilization and molecular size determination of the P2x purinoceptor from rat vas deferens.
Bo X; Simon J; Burnstock G; Barnard EA
J Biol Chem; 1992 Sep; 267(25):17581-7. PubMed ID: 1387637
[TBL] [Abstract][Full Text] [Related]
31. P2-receptor antagonists: IV. Blockade of P2-receptor subtypes and ecto-nucleotidases by compounds related to reactive blue 2.
Tuluc F; Bültmann R; Glänzel M; Frahm AW; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):111-20. PubMed ID: 9521483
[TBL] [Abstract][Full Text] [Related]
32. The selective P2X purinoceptor agonist, beta,gamma-methylene-L-adenosine 5'-triphosphate, discriminates between smooth muscle and neuronal P2X purinoceptors.
Trezise DJ; Michel AD; Grahames CB; Khakh BS; Surprenant A; Humphrey PP
Naunyn Schmiedebergs Arch Pharmacol; 1995 Jun; 351(6):603-9. PubMed ID: 7675118
[TBL] [Abstract][Full Text] [Related]
33. Evidence that ATP acts at two sites to evoke contraction in the rat isolated tail artery.
McLaren GJ; Burke KS; Buchanan KJ; Sneddon P; Kennedy C
Br J Pharmacol; 1998 May; 124(1):5-12. PubMed ID: 9630336
[TBL] [Abstract][Full Text] [Related]
34. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
Ohmura T; Oshita M; Kigoshi S; Muramatsu I
Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
[TBL] [Abstract][Full Text] [Related]
35. The purinoceptors of the guinea-pig isolated taenia caeci.
Piper AS; Hollingsworth M
Eur J Pharmacol; 1995 Jul; 280(2):125-34. PubMed ID: 7589176
[TBL] [Abstract][Full Text] [Related]
36. Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.
Mateo J; Miras-Portugal MT; Castro E
Br J Pharmacol; 1996 Nov; 119(6):1223-32. PubMed ID: 8937727
[TBL] [Abstract][Full Text] [Related]
37. The effect of P2 receptor antagonists and ATPase inhibition on sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens.
Sneddon P; Westfall TD; Todorov LD; Todorova SM; Westfall DP; Nickel P; Kennedy C
Br J Pharmacol; 2000 Mar; 129(6):1089-94. PubMed ID: 10725256
[TBL] [Abstract][Full Text] [Related]
38. PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses.
Lambrecht G; Friebe T; Grimm U; Windscheif U; Bungardt E; Hildebrandt C; Bäumert HG; Spatz-Kümbel G; Mutschler E
Eur J Pharmacol; 1992 Jul; 217(2-3):217-9. PubMed ID: 1330591
[TBL] [Abstract][Full Text] [Related]
39. α,β-meATP mimics the effects of the purinergic neurotransmitter in the human and rat colon.
Martínez-Cutillas M; Gil V; Gallego D; Mañé N; Clavé P; Martín MT; Jiménez M
Eur J Pharmacol; 2014 Oct; 740():442-54. PubMed ID: 24998877
[TBL] [Abstract][Full Text] [Related]
40. Reactive red 2: a P2y-selective purinoceptor antagonist and an inhibitor of ecto-nucleotidase.
Bültmann R; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):477-82. PubMed ID: 8751075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
